February 28, 2022
Xilio Therapeutics to Participate in the Cowen 42nd Annual Healthcare Conference
February 3, 2022
Xilio Therapeutics to Participate in the Guggenheim 4th Annual Oncology Day
January 20, 2022
Xilio Therapeutics Announces Initiation of Patient Dosing in Phase 1/2 Clinical Trial of XTX202 for the Treatment of Patients with Solid Tumors
January 6, 2022
Xilio Therapeutics Appoints Yuan Xu, Ph.D., to its Board of Directors
Displaying 11 - 14 of 14